David Kao

Keine laufenden Positionen mehr

Consumer Services

Health Technology

Profil

David Kao is Vice President-Regulatory Affairs at Inhibrx Biosciences, Inc. since 2021.
Former positions include Vice President-Regulatory Affairs at Sanofi AATD, Inc. from 2021 to 2024 and Head-Development Program at Bristol Myers Squibb Co. Education includes undergraduate studies at Rutgers State University of New Jersey, a doctorate from Shenandoah University, and an MBA from Rutgers Business School.

Aktive Positionen von David Kao

Unternehmen	Position	Beginn

Alle aktiven Positionen von David Kao

Ehemalige bekannte Positionen von David Kao

Unternehmen	Position	Ende
INHIBRX, INC.	General Counsel	30.05.2024
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von David Kao im Detail an

Ausbildung von David Kao

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von David Kao im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Rutgers State University of New Jersey Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Shenandoah University Shenandoah University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rutgers Business School Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inhibrx, Inc. Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer	Health Technology